ZetrOZ Systems’ sam 2.0 Wearable Ultrasound Unit Receives New FDA Clearance for Expanded Medical Indications

Share This Post

Agency’s decision signifies that ZetrOZ’s sustained acoustic medicine technology is safe and effective for promoting injury healing in wider range of medical conditions.

The sam® 2.0 long-duration wearable ultrasound unit from ZetrOZ Systems was cleared by the the U.S. Food and Drug Administration for expanded indications to treat soft tissue injuries and knee osteoarthritis, a decision that will make the sustained acoustic medicine device more readily available to patients with a wider range of medical conditions.

Specifically, sam® 2.0 clinical efficacy studies supported the new FDA indications for the treatment of knee osteoarthritis, upper back myofascial pain, and shoulder, elbow, and ankle tendinopathy.

With its effectiveness documented in more than 40 studies, ZetrOZ Systems’ sustained acoustic medicine has been popular with professional, college and amateur athletes for the treatment of a variety of sports injuries. The FDA’s clearance of expanded indications for the sam® device means it may be safely and effectively used in more conditions that affect the general population. Knee osteoarthritis, for example, affects an estimated 32 million people in the United States.

FDA clearance also has significance for health care providers and health insurance companies, indicating to physicians that they can prescribe the ZetrOZ sam® device with confidence and paving the way for insurers to eventually cover the treatment.

“We’re thrilled that the sam® wearable ultrasound unit is now FDA-cleared for expanded medical indications,” said George K. Lewis, founder and CEO of ZetrOZ Systems. “Dozens of studies over the last decade have shown that our sustained acoustic medicine technology effectively treats numerous types of injuries. This FDA clearance will make it easier for doctors and their patients to utilize our ultrasound treatment to speed injury healing without the need for oral medication, corticosteroids, or surgery.”

The effectiveness of sam® in treating soft tissue and other injuries has been documented in 42 peer-reviewed publications and 20 Level 1-5 clinical studies and is protected by 46 U.S. patents. ZetrOZ's sam® devices are the only FDA-cleared wearable ultrasound units approved for daily use at home. ZetrOZ's technology was developed, in part, with funding from the National Institute of Health, National Science Foundation, Department of Defense, and NASA.

For more information on ZetrOZ Systems and the revolutionary sam® 2.0 ultrasound device, please visit www.samrecover.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of 46 patents and is the exclusive manufacturer and developer of the sam® product line, which is designed for the treatment of acute and chronic musculoskeletal conditions.

Contact Information:
Maria Penaloza
maria.penaloza@newswire.com


Original Source: ZetrOZ Systems’ sam 2.0 Wearable Ultrasound Unit Receives New FDA Clearance for Expanded Medical Indications

Related Posts

Kids Get in Free: High School Baseball National Championship Series, Presented by Stinger Sports, Set for June 27-30 at Charles Schwab Field, Omaha, NE

The best-of-the-best high school baseball players from across the country are coming to Omaha. See the stars of tomorrow battle it out on the biggest stage. ...

FTC Data Shows Major Increases in Cash Payments to Government Impersonation Scammers

New Federal Trade Commission data reveals that government impersonation...

Introducing $UTHX, the Preeminent Metaverse Token on the Solana Blockchain

Utherverse (Utherverse.io) announces the August 2024 launch of $UTHX Utherverse Utherverse LOS ANGELES, June 14, ...

SWTHZ (SweatHouz) Appoints Dr. Susanna Søberg, PhD as Lead Science and Education Advisor

ATLANTA, June 13, 2024 (Newswire.com) - SWTHZ, the leader in boutique wellness and contrast therapy, is excited to announce the appointment of Dr. Susanna Søb...

Two Leading Student Transportation Technology Groups Announce Integration to Serve Joint Customers

Bytecurve and BusPlanner integration delivers opportunity for improved performance for hundreds of school bus fleets ...
green agriculture project
- Part of VUGA Media group -best seo company